Citadel Advisors’s ProShares S&P 500 ex-Health Care ETF SPXV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-14,620
Closed -$624K 15182
2023
Q1
$624K Buy
14,620
+2,546
+21% +$105K ﹤0.01% 7841
2022
Q4
$471K Buy
12,074
+4,386
+57% +$173K ﹤0.01% 8369
2022
Q3
$283K Hold
7,688
﹤0.01% 9712
2022
Q2
$298K Buy
7,688
+1,000
+15% +$42.6K ﹤0.01% 9812
2022
Q1
$318K Hold
6,688
﹤0.01% 10470
2021
Q4
$333K Sell
6,688
-14
-0.2% -$679 ﹤0.01% 10697
2021
Q3
$303K Hold
6,702
﹤0.01% 11049
2021
Q2
$303K Buy
+6,702
New +$295K ﹤0.01% 11247

Other funds holding SPXV

Citadel Advisors's SPXV Position: Q2 2023 in Review

Citadel Advisors sold out of ProShares S&P 500 ex-Health Care ETF (SPXV) in Q2 2023, closing a stake of 14,620 shares — an estimated $624K sold.

Citadel Advisors first reported a position in SPXV in Q2 2021 and held it in 8 quarters. The position peaked at $624K in Q1 2023. 10 funds tracked by Wall St. Rank hold SPXV as of Q2 2023.

  • Citadel Advisors reported no remaining ProShares S&P 500 ex-Health Care ETF position as of Q2 2023 after selling out during the quarter.
  • Citadel Advisors sold 14,620 ProShares S&P 500 ex-Health Care ETF shares in Q2 2023, an estimated $624K.
  • Citadel Advisors first reported a position in ProShares S&P 500 ex-Health Care ETF in Q2 2021 and held it in 8 quarters.
  • Citadel Advisors's ProShares S&P 500 ex-Health Care ETF position peaked at $624K in Q1 2023.
  • 10 funds tracked by Wall St. Rank held ProShares S&P 500 ex-Health Care ETF as of Q2 2023.

Based on Citadel Advisors's 13F filing for Q2 2023, filed 14 Aug 2023.